Nobiletin, a Polymethoxylated Flavone, Inhibits Glioma Cell Growth and Migration via Arresting Cell Cycle and Suppressing MAPK and Akt Pathways

Li Ming Lien, Meng Jiy Wang, Ray Jade Chen, Hou Chang Chiu, Jia Lun Wu, Ming Yi Shen, Duen Suey Chou, Joen Rong Sheu, Kuan Hung Lin, Wan-Jung Lu

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Nobiletin, a bioactive polymethoxylated flavone (5,6,7,8,3',4'-hexamethoxyflavone), is abundant in citrus fruit peel. Although nobiletin exhibits antitumor activity against various cancer cells, the effect of nobiletin on glioma cells remains unclear. The aim of this study was to determine the effects of nobiletin on the human U87 and Hs683 glioma cell lines. Treating glioma cells with nobiletin (20-100 μm) reduced cell viability and arrested the cell cycle in the G0/G1 phase, as detected using a 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay and propidium iodide (PI) staining, respectively; however, nobiletin did not induce cell apoptosis according to PI-annexin V double staining. Data from western blotting showed that nobiletin significantly attenuated the expression of cyclin D1, cyclin-dependent kinase 2, cyclin-dependent kinase 4, and E2 promoter-binding factor 1 (E2F1) and the phosphorylation of Akt/protein kinase B and mitogen-activated protein kinases, including p38, extracellular signal-regulated kinase, and c-Jun N-terminal kinase. Our data also showed that nobiletin inhibited glioma cell migration, as detected by both functional wound healing and transwell migration assays. Altogether, the present results suggest that nobiletin inhibits mitogen-activated protein kinase and Akt/protein kinase B pathways and downregulates positive regulators of the cell cycle, leading to subsequent suppression of glioma cell proliferation and migration. Our findings evidence that nobiletin may have potential for treating glioblastoma multiforme.

Original languageEnglish
Pages (from-to)214-221
Number of pages8
JournalPhytotherapy Research
Volume30
Issue number2
DOIs
Publication statusPublished - Feb 1 2016

Fingerprint

flavone
Glioma
Cell Movement
Cell Cycle
Growth
Proto-Oncogene Proteins c-akt
Propidium
nobiletin
Cyclin-Dependent Kinase 4
Cyclin-Dependent Kinase 2
Staining and Labeling

Keywords

  • Akt
  • cell cycle
  • glioblastoma multiforme
  • MAPKs
  • nobiletin

ASJC Scopus subject areas

  • Pharmacology

Cite this

Nobiletin, a Polymethoxylated Flavone, Inhibits Glioma Cell Growth and Migration via Arresting Cell Cycle and Suppressing MAPK and Akt Pathways. / Lien, Li Ming; Wang, Meng Jiy; Chen, Ray Jade; Chiu, Hou Chang; Wu, Jia Lun; Shen, Ming Yi; Chou, Duen Suey; Sheu, Joen Rong; Lin, Kuan Hung; Lu, Wan-Jung.

In: Phytotherapy Research, Vol. 30, No. 2, 01.02.2016, p. 214-221.

Research output: Contribution to journalArticle

@article{6916b1c0b57b4c2a8ecd3754bc174308,
title = "Nobiletin, a Polymethoxylated Flavone, Inhibits Glioma Cell Growth and Migration via Arresting Cell Cycle and Suppressing MAPK and Akt Pathways",
abstract = "Nobiletin, a bioactive polymethoxylated flavone (5,6,7,8,3',4'-hexamethoxyflavone), is abundant in citrus fruit peel. Although nobiletin exhibits antitumor activity against various cancer cells, the effect of nobiletin on glioma cells remains unclear. The aim of this study was to determine the effects of nobiletin on the human U87 and Hs683 glioma cell lines. Treating glioma cells with nobiletin (20-100 μm) reduced cell viability and arrested the cell cycle in the G0/G1 phase, as detected using a 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay and propidium iodide (PI) staining, respectively; however, nobiletin did not induce cell apoptosis according to PI-annexin V double staining. Data from western blotting showed that nobiletin significantly attenuated the expression of cyclin D1, cyclin-dependent kinase 2, cyclin-dependent kinase 4, and E2 promoter-binding factor 1 (E2F1) and the phosphorylation of Akt/protein kinase B and mitogen-activated protein kinases, including p38, extracellular signal-regulated kinase, and c-Jun N-terminal kinase. Our data also showed that nobiletin inhibited glioma cell migration, as detected by both functional wound healing and transwell migration assays. Altogether, the present results suggest that nobiletin inhibits mitogen-activated protein kinase and Akt/protein kinase B pathways and downregulates positive regulators of the cell cycle, leading to subsequent suppression of glioma cell proliferation and migration. Our findings evidence that nobiletin may have potential for treating glioblastoma multiforme.",
keywords = "Akt, cell cycle, glioblastoma multiforme, MAPKs, nobiletin",
author = "Lien, {Li Ming} and Wang, {Meng Jiy} and Chen, {Ray Jade} and Chiu, {Hou Chang} and Wu, {Jia Lun} and Shen, {Ming Yi} and Chou, {Duen Suey} and Sheu, {Joen Rong} and Lin, {Kuan Hung} and Wan-Jung Lu",
year = "2016",
month = "2",
day = "1",
doi = "10.1002/ptr.5517",
language = "English",
volume = "30",
pages = "214--221",
journal = "Phytotherapy Research",
issn = "0951-418X",
publisher = "John Wiley and Sons Ltd",
number = "2",

}

TY - JOUR

T1 - Nobiletin, a Polymethoxylated Flavone, Inhibits Glioma Cell Growth and Migration via Arresting Cell Cycle and Suppressing MAPK and Akt Pathways

AU - Lien, Li Ming

AU - Wang, Meng Jiy

AU - Chen, Ray Jade

AU - Chiu, Hou Chang

AU - Wu, Jia Lun

AU - Shen, Ming Yi

AU - Chou, Duen Suey

AU - Sheu, Joen Rong

AU - Lin, Kuan Hung

AU - Lu, Wan-Jung

PY - 2016/2/1

Y1 - 2016/2/1

N2 - Nobiletin, a bioactive polymethoxylated flavone (5,6,7,8,3',4'-hexamethoxyflavone), is abundant in citrus fruit peel. Although nobiletin exhibits antitumor activity against various cancer cells, the effect of nobiletin on glioma cells remains unclear. The aim of this study was to determine the effects of nobiletin on the human U87 and Hs683 glioma cell lines. Treating glioma cells with nobiletin (20-100 μm) reduced cell viability and arrested the cell cycle in the G0/G1 phase, as detected using a 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay and propidium iodide (PI) staining, respectively; however, nobiletin did not induce cell apoptosis according to PI-annexin V double staining. Data from western blotting showed that nobiletin significantly attenuated the expression of cyclin D1, cyclin-dependent kinase 2, cyclin-dependent kinase 4, and E2 promoter-binding factor 1 (E2F1) and the phosphorylation of Akt/protein kinase B and mitogen-activated protein kinases, including p38, extracellular signal-regulated kinase, and c-Jun N-terminal kinase. Our data also showed that nobiletin inhibited glioma cell migration, as detected by both functional wound healing and transwell migration assays. Altogether, the present results suggest that nobiletin inhibits mitogen-activated protein kinase and Akt/protein kinase B pathways and downregulates positive regulators of the cell cycle, leading to subsequent suppression of glioma cell proliferation and migration. Our findings evidence that nobiletin may have potential for treating glioblastoma multiforme.

AB - Nobiletin, a bioactive polymethoxylated flavone (5,6,7,8,3',4'-hexamethoxyflavone), is abundant in citrus fruit peel. Although nobiletin exhibits antitumor activity against various cancer cells, the effect of nobiletin on glioma cells remains unclear. The aim of this study was to determine the effects of nobiletin on the human U87 and Hs683 glioma cell lines. Treating glioma cells with nobiletin (20-100 μm) reduced cell viability and arrested the cell cycle in the G0/G1 phase, as detected using a 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay and propidium iodide (PI) staining, respectively; however, nobiletin did not induce cell apoptosis according to PI-annexin V double staining. Data from western blotting showed that nobiletin significantly attenuated the expression of cyclin D1, cyclin-dependent kinase 2, cyclin-dependent kinase 4, and E2 promoter-binding factor 1 (E2F1) and the phosphorylation of Akt/protein kinase B and mitogen-activated protein kinases, including p38, extracellular signal-regulated kinase, and c-Jun N-terminal kinase. Our data also showed that nobiletin inhibited glioma cell migration, as detected by both functional wound healing and transwell migration assays. Altogether, the present results suggest that nobiletin inhibits mitogen-activated protein kinase and Akt/protein kinase B pathways and downregulates positive regulators of the cell cycle, leading to subsequent suppression of glioma cell proliferation and migration. Our findings evidence that nobiletin may have potential for treating glioblastoma multiforme.

KW - Akt

KW - cell cycle

KW - glioblastoma multiforme

KW - MAPKs

KW - nobiletin

UR - http://www.scopus.com/inward/record.url?scp=84956958860&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84956958860&partnerID=8YFLogxK

U2 - 10.1002/ptr.5517

DO - 10.1002/ptr.5517

M3 - Article

C2 - 26560814

AN - SCOPUS:84956958860

VL - 30

SP - 214

EP - 221

JO - Phytotherapy Research

JF - Phytotherapy Research

SN - 0951-418X

IS - 2

ER -